Back to the Top
Dear Dr. Hutson
I came across your query from 2004:
>We have a drug that is said to be soluble only in DMSO that we would
like to administer IP to mice. Recognizing the later issues with
trying to switch to practical formulations for human trials, can
anyone provide information on the maximal concentration and dose of
DMSO tolerated IP? Many thanks Paul
I have exactly the same question as you. Did you use DMSO to dissolve
the drug and what dilution did you use? I want to administer
dexamethasone and am going to try to dilute out the DMSO by 1:100.
I would be grateful for any advice
Thanks
Margaret Kelly
Back to the Top
The following message was posted to: PharmPK Margaret:
I never got an answer from PharmPK. We ended up using 2-hydroxy-beta
cyclodextrin to solubilize the goo. Thanks for your interest.
Paul
Back to the Top
The following message was posted to: PharmPK
Dear Margaret,
We find that Dexamethasone is active down to doses in the order of
0.03 - 0.01 mg/kg/day p.o. in mice (e.g. DBA1). In that range, you
should not have many problems. Dex is essentially just as active p.o.
as i.p. and this may help further.
Depending on the model and the signs you are interested in you may
consider PEG300 as a solvent for a stock solution of substance and
here I would be interested in the view of the group. To my experience
parenteral PEG is mainly an issue where impurities in the PEG itself
may lead to kidney damage under chronic application or where PEG will
disrupt analytics in PK (usually not an issue with dex).
If you do go for cyclodextrin (not sure if this is OK parenterally)
try making a stock of dex in ethanol, then drying this in combination
with cyclodextrin, then dissolving it again in water to the desired
concentration.
Best regards
Michael
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "IP DMSO in mouse" as the subject | Support PharmPK by using the |
Copyright 1995-2011 David W. A. Bourne (david@boomer.org)